Testosterone Treatment Lawsuit News: Alonso Krangle LLP Commends Public Citizen’s Call for Heart Attack Warnings on Low Testosterone Therapy Drugs

Share Article

Public Citizen’s Call for Testosterone Heart Attack Warnings Follows Launch of FDA Investigation into Low T Heart Risks, Filing of Several AndroGel Lawsuits.

Testosterone Treatment Lawsuit

Consumer advocacy group, Public Citizen, Petition For new heart attack warnings on Testosterone Treatment Drugs Such As AndroGel

If you or a loved one has experienced serious side-effects from Low Testosterone Therapy please contact Alonso Krangle LLP for a free consulation at 1-800-403-6191 or by visting fightforvictims.com

Alonso Krangle LLP, an experienced law firm investigating testosterone treatment lawsuits involving AndroGel and other prescription low testosterone, or Low T, therapies, commends the consumer advocacy group, Public Citizen, on its petition calling for new heart attack warnings on this class of medications. According to a statement issued by the group on February 25, 2014, Public Citizen has petitioned the U.S. Food & Drug Administration (FDA) to immediately add black box warnings, the most serious type of safety notice, to the label of AndroGel and other Low T therapies in order to alert the public of their potential to cause heart attacks and other serious cardiovascular problems.
[citizen.org/pressroom/pressroomredirect.
cfm?ID=4092, February 25, 2014]

The Public Citizen petition follows the January 31, 2014 announcement by the FDA that it was launching a safety review of prescription testosterone therapies after two studies indicated they may raise the risk of heart attacks, strokes, and other serious heart problems in certain men. One of those studies was published in the Journal of the American Medical Association (JAMA) in November 2013, and suggested that older men with underlying heart disease faced a 30-percent increased risk of stroke, heart attack, and death if they were undergoing testosterone therapy. A second observational study cited in the FDA alert suggested a doubling of the risk of heart attack in older men, as well as in younger men with pre-existing heart disease, who underwent testosterone therapy.
[fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/
ucm384225.htm, FDA, January 31, 2014]

Among other things, the Public Citizen petition points out that one analysis found that 14 of 27 studies published over the past 20 years linked prescription Low T therapies to highly significant increased cardiovascular risks. While the remaining 13 studies did not show a heighted risk of heart problems, all were funded by the pharmaceutical industry.
[citizen.org/documents/2184.pdf, Public Citizen, February 25, 2014]

Since the FDA alert was issued, court documents indicate that at least four AndroGel lawsuits have been filed in U.S. District Court, Northern District of Illinois in on behalf of plaintiffs who allegedly suffered heart attacks, heart failure and strokes, due to their use of the drug. All of these lawsuits raise questions regarding the marketing tactics used to drive sales of prescription testosterone treatments. Among other things, the complaints allege that aggressive direct-to-consumer advertising caused many men to seek out treatment, and to be prescribed these medications, even though they were not suffering from low testosterone levels. (Case Nos: 1:14-cv-00776, 1:14-cv-00780, 1:14-cv-00777, and 1:14-cv-00772)

In light of these developments, the testosterone treatment lawyers at Alonso Krangle LLC agree with Public Citizen that new warnings alerting patients and doctors to the potential heart risks associated with these medications are urgently needed. The Firm calls on the FDA to act as soon as possible in order to mitigate this serious public health threat.

The attorneys of Alonso Krangle LLP are offering free testosterone therapy lawsuit reviews to men who may have suffered serious heart problems due to AndroGel or a similar medication. To learn more, please contact one of the experienced consumer injury lawyers at Alonso Krangle LLP by calling 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

About Alonso Krangle LLP
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. A nationwide law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and New Jersey. To discuss filing a testosterone therapy lawsuit, please contact Alonso Krangle LLP at 1-800-403-6191 or visit our website, http://www.FightForVictims.com

For more information about Alonso Krangle LLP or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com

Contact:
Alonso Krangle LLP
445 Broad Hollow Road
Suite 205
Melville, New York 11747
Toll-FREE 1-800-403-6191
Tel: 516-350-5555
Fax: 516-350-5554
http://www.fightforvictims.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Krangle
Visit website